The workup as indicated in the guidelines includes (re)checking of newborn blood-screening results (galactosemia, hypothyroidism, cystic fibrosis), and blood analyses including measurement of white blood counts, differential alpha-1-antitrypsin level and phenotype, thyroid hormone and TSH, bile acid concentration, cortisol, glucose, lactate, and metabolic parameters. The gene discussed is SERPINA1; the disease is cystic fibrosis.